These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Growth factor receptors gene expression and Akt phosphorylation in benign human thyroid nodules are unaffected by chronic thyrotropin suppression. Sponziello ML; Bruno R; Durante C; D'Agostino M; Corradino R; Giannasio P; Ciociola E; Ferretti E; Maranghi M; Verrienti A; De Toma G; Filetti S; Russo D Horm Metab Res; 2011 Jan; 43(1):22-5. PubMed ID: 20886414 [TBL] [Abstract][Full Text] [Related]
3. [Results of thyroid hormone therapy in bland struma]. Meng W; Meng S; Hampel R; Ventz M; Zeisler A Z Gesamte Inn Med; 1982 Aug; 37(16):540-2. PubMed ID: 6815911 [TBL] [Abstract][Full Text] [Related]
4. High long term recurrence rate after subtotal thyroidectomy for nodular goitre. Röjdmark J; Järhult J Eur J Surg; 1995 Oct; 161(10):725-7. PubMed ID: 8555339 [TBL] [Abstract][Full Text] [Related]
5. [Percutaneous ethanol injection in combination with euthyrox suppressive therapy in the treatment of benign nodular goiter]. Meskhi IA; Sikharulidze EN; Natmeladze KV Georgian Med News; 2007 May; (146):11-3. PubMed ID: 17595451 [TBL] [Abstract][Full Text] [Related]
6. [Therapy with L-thyroxine in thyroid struma. Study with ultrasonic evaluation]. Peta M; Cartasegna S; Fabiani MP; Macchi R; Vecchi G; Costantino D Recenti Prog Med; 1989 Jun; 80(6):320-5. PubMed ID: 2672195 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of thyroid hormone suppression for benign thyroid nodules: meta-analysis of randomized trials. Sdano MT; Falciglia M; Welge JA; Steward DL Otolaryngol Head Neck Surg; 2005 Sep; 133(3):391-6. PubMed ID: 16143188 [TBL] [Abstract][Full Text] [Related]
8. [Effectiveness of goiter treatment with L-thyroxine in patients over 40]. Wollmann B; Meller J; Hüfner M; Becker W Nuklearmedizin; 1998 Jan; 37(1):41-4. PubMed ID: 9467169 [TBL] [Abstract][Full Text] [Related]
10. Radioiodine therapy in non-toxic multinodular goitre. The possibility of effect-amplification with recombinant human TSH (rhTSH). Bonnema SJ; Nielsen VE; Hegedüs L Acta Oncol; 2006; 45(8):1051-8. PubMed ID: 17118838 [TBL] [Abstract][Full Text] [Related]
11. Treatment of benign nodular goitre with mildly suppressive doses of L-thyroxine: effects on bone mineral density and on nodule size. Baldini M; Gallazzi M; Orsatti A; Fossati S; Leonardi P; Cantalamessa L J Intern Med; 2002 May; 251(5):407-14. PubMed ID: 11982740 [TBL] [Abstract][Full Text] [Related]
13. Effects of thyroxine replacement on lipid profile and endothelial function after thyroidectomy. Erbil Y; Ozbey N; Giriş M; Salmaslioğlu A; Ozarmağan S; Tezelman S Br J Surg; 2007 Dec; 94(12):1485-90. PubMed ID: 17703499 [TBL] [Abstract][Full Text] [Related]
15. Dosimetry of radioiodine therapy in patients with nodular goiter after pretreatment with a single, low dose of recombinant human thyroid-stimulating hormone. Nieuwlaat WA; Hermus AR; Ross HA; Buijs WC; Edelbroek MA; Bus JW; Corstens FH; Huysmans DA J Nucl Med; 2004 Apr; 45(4):626-33. PubMed ID: 15073259 [TBL] [Abstract][Full Text] [Related]
16. Nodular goiter--is thyroxine medication of any value? Persson CP; Johansson H; Westermark K; Karlsson FA World J Surg; 1982 Jul; 6(4):391-6. PubMed ID: 6812295 [No Abstract] [Full Text] [Related]